STAT· @statnews · X·· 13 天前精选AI 评分58
AI 导读
Ultragenyx 宣布将裁员约20%,同时终止两款罕见病药物的开发。公司未在材料中披露具体药物名称及裁员涉及人数。
推荐理由
Ultragenyx 裁员约20%并终止两款罕见病药物开发,读者可据此观察其管线收缩的幅度。
正文
Ultragenyx announced that it's laying off about 20% of its staff as it ends development of two rare disease drugs. https://trib.al/bqamcYm
来源:STAT · x.com